The new Class I recall includes nearly 27,000 devices that could potentially experience a harmful defect during use. 

After their proposal for a new American Board of Cardiovascular Medicine was shot down earlier this year, cardiology groups have asked the AMA for some support. "We feel like it's time for us to blaze our own path," one specialist explained. 

American Medical Association President Bruce Scott, MD, explains the growing issues with insurance prior authorization impacting patient care and what the AMA is doing about it.

Use of the drug more than doubles a person's risk of dying from heart disease, according to a new analysis of 24 different studies. In a separate editorial, two physicians shared their concerns and highlighted the importance of discussing these risks with patients.

"Eliminating this flexibility would significantly reduce outpatient imaging capacity, forcing many patients to seek services in hospital-based settings," the RBMA contends. 

The American College of Emergency Physicians contends the law change would restore physicians’ freedom to choose where they practice and protect their clinical autonomy. 

A report from the Guardian details how the VA removed language protecting patients from discrimination based on political affiliation and lifestyle. The department denies that there has been any actual change in policy.

There is an increased risk that these devices will not provide audible alerts for low or high blood glucose levels. The FDA has ruled that this is a Class I recall, highlighting the safety risks associated with missed alerts.